Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199754 · ClinicalTrials.gov registry record · Early Phase 1
IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy
A Early Phase 1 study, sponsored by Columbia University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT04199754 is a Early Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 6 participants.
The verdict
NCT04199754, a Early Phase 1 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if giving intravenous (IV) contrast (a liquid that helps with the visibility of organs and blood vessels that is given through the vein with the use of a hollow needle) during a Cone Beam Computed Tomography (CBCT- a type of computerized X-ray) can help people who have image guided radiation therapy (IGRT) for the treatment of abdominal and pelvic tumors.
Interventions
- RADIATION Radiation Therapy
- DRUG 0.9% Saline
- RADIATION Cone Beam CT
- DRUG Omnipaque 300mg/mL Solution for Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-05-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04199754
The ClinicalTrials.gov registry entry for NCT04199754 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Radiation Therapy is the first listed.
NCT04199754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04199754 about?
NCT04199754 is a clinical study titled "IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy". The purpose of this study is to find out if giving intravenous (IV) contrast (a liquid that helps with the visibility of organs and blood vessels that is given through the vein with the use of a hollow needle) during a Cone Beam Computed Tomography (CBCT- a type of computerized X-ray) can help peopl...
What is the current status of trial NCT04199754?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2020-10-01. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT04199754?
The interventions under investigation include: Radiation Therapy (RADIATION), 0.9% Saline (DRUG), Cone Beam CT (RADIATION), Omnipaque 300mg/mL Solution for Injection (DRUG).
Who is sponsoring clinical trial NCT04199754?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.